Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
We're super excited to welcome a phenomenal guest, Michael Parini!
Michael is the CEO of Spur Therapeutics, a clinical-stage biotechnology company dedicated to developing transformative gene therapies for chronic debilitating diseases. With over 20 years of experience as a senior executive in the biopharma and biotech industries, Michael has held key roles at Vertex and Pfizer before joining Spur.
In this episode, we’ll dive into the exciting rebrand of Freeline now spur, what inspired Michael to join the company, and how Spur is approaching gene therapy in innovative ways. We’ll also discuss the challenges of reshaping the company, maintaining stability and culture, the importance of diversity and inclusion, and how Freeline is making a difference for patients.
Enjoy and stay tuned